Shopping Cart
Remove All
Your shopping cart is currently empty
DS17701585 is an orally active, selective inhibitor of EP300 and CBP, capable of acting on CBP (IC50: 0.040 μM), EP300 (IC50: 0.15 μM), H3K27 (IC50: 0.45 μM) and SOX2 (IC50: 0.7 μM), and can be used to study cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $1,980 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $2,500 | 10-14 weeks | 10-14 weeks |
| Description | DS17701585 is an orally active, selective inhibitor of EP300 and CBP, capable of acting on CBP (IC50: 0.040 μM), EP300 (IC50: 0.15 μM), H3K27 (IC50: 0.45 μM) and SOX2 (IC50: 0.7 μM), and can be used to study cancer. |
| Targets&IC50 | CBP:0.15 μM, EP300:0.04 μM, H3K27:0.45 μM, SOX2:0.70 μM |
| Molecular Weight | 482.55 |
| Formula | C24H26N4O5S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.